Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2266457
Reference Type
Journal Article
Subtype
Abstract
Title
Inducible nitric oxide synthase and 3-nitrotyrosine are expressed in alveolar eosinophils in chronic eosinohpilic pneumonia
Author(s)
Nakaji, H; Matsumoto, H; Niimi, A; Ito, I; Handa, T; Nomura, M; Tabata, H; Iwata, T; Tajiri, T; Inoue, H; Oguma, T; Otsuka, K; Takeda, T; Mochizuki, Y; Mishima, M
Year
2010
Is Peer Reviewed?
Yes
Journal
American Journal of Respiratory and Critical Care Medicine
ISSN:
1073-449X
EISSN:
1535-4970
Volume
181
Page Numbers
A2788
Language
English
DOI
10.1164/ajrccm-conference.2010.181.1_MeetingAbstracts.A2788
Web of Science Id
WOS:000208771001701
Relationship(s)
is part of a larger document
3452678
Proceedings of the American Thoracic Society 2010 International Conference, May 14-19, 2010, New Orleans
Abstract
RATIONALE: Inducible nitric oxide synthase (iNOS) that mediates nitric oxide (NO) synthesis in inflamed airways is thought to be expressed in epithelial cells and inflammatory cells such as macrophages. However iNOS expression in eosinophils in respiratory diseases including chronic eosinophilic pneumonia (CEP) has been rarely reported. Since NO promotes eosinophil migration into the airways and initiates nitrative stress, we hypothesized that iNOS and 3-nitrotyrosine (3NT), a metabolite of peroxynitrate, may be consistently expressed in eosinophils in CEP,resulting in eosinophil accumulation by NO leading to self-perpetuating and augment tissue damage in CEP.
METHODS: We examined lung tissues from three patients with CEP. In all cases surgical biopsy was necessary to exclude other possible diagnosis such as cryptogenic organizing pneumonia, and final diagnosis of CEP was established on the basis of eosinophil accumulation in the alveolar lumen and septa. Immunostaining was performed to examine whether eosinophils expressed iNOS and 3NT. In one case exhaled NO levels were measured at multiple flows with a chemiluminescence analyzer and bronchial and alveolar fractions of NO levels were calculated using a two-compartment model (Tsoukias et al, J Appl Physiol 1998).
RESULTS: In all cases, eosinophils in the alveolar lumen and septa clearly expressed iNOS and 3NT. After initiation of oral prednisolone, bronchial and alveolar NO levels determined in one case decreased in parallel with the improvement of symptoms and radiological lung infiltrates.
CONCLUSION: Expression of 3NT, possibly resulting from iNOS expression and NO formation in eosinophils, may play an important role in the pathophysiology of CEP.
Conference Name
American Thoracic Society 2010 International Conference
Conference Location
New Orleans, LA
Conference Dates
May 14-19, 2010
Tags
•
LitSearch-NOx (2024)
Keyword Search
Toxicology
March 2014-November 2016
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity